Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calcineurin-like phosphoesterase domain-containing protein 1 (CPPED1) is a human serine/threonine protein phosphatase and member of the calcineurin-like metallophosphoesterase superfamily. It specifically dephosphorylates AKT kinases at Ser-473, thereby acting as a negative regulator of the PI3K-AKT signaling pathway, blocking cell cycle progression, and promoting apoptosis. It may also play a role in inhibiting glucose uptake by adipocytes and be involved in chromatin remodeling as well as transcriptional regulation. CPPED1 is found in the cytosol and plasma membrane. Reduced protein levels have been noted in the placenta during term labor, suggesting additional regulation roles in pregnancy.
Inhibitors would be expected to potentiate PI3K-AKT signaling via maintained phosphorylation of AKT; activators or increased expression would be expected to suppress the pathway and promote apoptosis or cell cycle arrest. However, there are currently no known specific drugs targeting CPPED1
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcineurin-like phosphoesterase domain-containing protein 1 (CPPED1).